Document Detail

Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
MedLine Citation:
PMID:  22882859     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Enoxaparin is routinely used for prevention of venous thromboembolism (VTE) after total hip or knee arthroplasty. The purpose of this study was to compare the efficacy and safety of apixaban, a newly oral direct inhibitor of factor Xa versus enoxaparin.
METHODS: We performed a meta-analysis of relevant randomized-controlled trials (RCTs) identified in PubMed, Cochrane Library, Embase China Biological Medical Literature database, Countries Journal full-text database, VIP database, and WanFang database. The primary efficacy outcome for our meta-analysis was all VTE and all-cause mortality. The secondary efficacy outcomes included major VTE, non-fatal pulmonary embolism, and mortality. The primary safety outcome was bleeding events, categorized as major, clinically relevant non-major, or minor events.
RESULTS: Four RCTs, involving 14 065 patients, were included in our meta-analysis. Compared to enoxaparin, thromboprophylaxis with apixaban was associated with significantly fewer VTE and all-cause mortality (8346 patients, risk ratio (RR): 0.63, 95%CI 0.42 - 0.95) and similar incidence of bleeding events (major bleeding, 11 525 patients, RR 0.76, 95%CI 0.43 - 1.33; clinically relevant non-major bleeding, 11 525 patients, RR 0.83, 95%CI 0.69 - 1.01; and minor bleeding, 11 828 patients, RR 0.93, 95%CI 0.79 - 1.09). However, our meta-analysis revealed similar effects of apixaban with enoxaparin for thromboprophylaxis with regard to the secondary efficacy outcomes.
CONCLUSIONS: Apixaban was more effective than recommended dose of enoxaparin and had a similar safety profile for thromboprophylaxis after hip and knee arthroplasty. But more evidence, especially well designed head-to-head RCTs, is needed to confirm the superior efficacy of apixaban.
Xiu-Min Li; Shi-Guang Sun; Wei-Dong Zhang
Related Documents :
22506249 - Treatment of dysphagia with pyridostigmine bromide in a patient with the pharyngeal-cer...
19084419 - Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mort...
8720539 - A 5-year (1989-1993) prospective study of the incidence of iddm in rome and the lazio r...
22497779 - The effect of nesiritide on renal function and other clinical parameters in patients wi...
22438779 - Anesthetic management for wingspan stent.
20863649 - The prognosis of patients with dissociated virological and immunological responses to h...
17482849 - Rapid quantitative determination of c-reactive protein at chair side in dental emergenc...
23706859 - Open appendectomy for pediatric ruptured appendicitis: a historical clinical review of ...
10506769 - Clinical and angiographic follow-up after balloon angioplasty with provisional stenting...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  125     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-08-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  2339-45     Citation Subset:  IM    
Department of Pharmacy, the Military General Hospital of Beijing PLA, Beijing 100700, China (Email:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in p...
Next Document:  High mobility group box 1 protein: possible pathogenic link to atrial fibrillation.